Drugs in R&D logo Adis International logo

Publisher: Adis International

Volume 6, Number 1, 2005
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Original Research Article

Correlation between Seminal Carnitine and Functional Spermatozoal Characteristics in Men with Semen Dysfunction of Various Origins
pp. 1-9(9)
Authors: Michele De Rosa; Bartolomeo Boggia; Biagio Amalfi; Stefano Zarrilli; Angela Vita; Annamaria Colao; Gaetano Lombardi

Effects of Concurrent Therapy with Policosanol and Omega-3 Fatty Acids on Lipid Profile and Platelet Aggregation in Rabbits
pp. 11-19(9)
Authors: R. Gámez; R. Más; M.L. Arruzazabala; S. Mendoza; G. Castaño

Utilisation of Human Pharmacology Studies with Biomarkers for New Drug Applications in Japan
pp. 21-34(14)
Authors: Yasuo Kodama; Kazuyuki Saito; Shunsuke Ono; Hirofumi Kodama; Masae Kuranari; Kimiko Tsutsumi; Deborah F. Yaplee; Hiromi Takano-Ohmuro; Mizue Mutoh; Akio Fujimura

Erythrocyte Glutathione Levels in Lithium-Induced Hypothyroidism
pp. 35-40(6)
Authors: Atilla Engin; Nilgun Altan; Erdal Isik

Leading Article

Pharmacokinetics and Pilot Efficacy of a Mesalazine Rectal Gel in Distal Ulcerative Colitis
pp. 41-46(6)
Authors: Guy Aumais; Marc Lefebvre; Julie Massicotte; Claude Tremblay; Joelle Kasbo; Jean-Sébastien Brunet; Cynthia Cardinal; Michael Grace; Jean Spénard

rnd-profile

Glufosfamide: Beta-D-Glc-IPM, D 19575
pp. 49-52(4)
Author: Adis International Limited

Lasofoxifene: CP 336156, CP-336156
pp. 56-60(5)
Author: Adis International Limited

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A